Lactation Drug Cabergoline May Cut Postpartum Breast Cancer Risk, Study Finds
A widely used lactation-suppressing drug, cabergoline, was linked to a sharply lower postpartum breast cancer risk in women and halved ...
A widely used lactation-suppressing drug, cabergoline, was linked to a sharply lower postpartum breast cancer risk in women and halved ...
A new evolutionary analysis shows that NOTCH1 mutations flourish in normal esophageal tissue but epistatically suppress the later driver mutations, ...
A landmark analysis of nearly 60,000 cancer patients reveals that cachexia occurs in recurring episodes tied to tumor genetics and ...
A machine learning framework called BioBombe maps the biological processes that cancers depend on for survival, revealing new vulnerabilities and ...
Researchers at Tokushima University found that combined TP53 and CDKN2A mutations activate cGAS–STING-mediated antitumor immunity, delaying progression to invasive oral ...
A computational screen of 1,000 plant compounds identifies the steroidal saponin hecogenin as a leading multitarget inhibitor candidate against Epstein–Barr ...
A Johns Hopkins study shows chronic cigarette smoke exposure reprograms distinct lung stem cell populations through epigenetic changes, determining whether ...
Researchers have discovered Δ246p53, a conserved 18-kilodalton p53 isoform translated from codon 246 that responds to DNA damage and enhances ...
A comprehensive multi-omics study catalogues thousands of cancer-specific isoform switches in melanoma, ovarian cancer, and AML, showing that most disrupt ...
New research shows carboplatin drives the expansion of TP53-mutant blood clones far more strongly than PARP inhibitors, while inherited homologous ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine